Abivax S.A. Interest Paid Classified As Financing Activities
Abivax S.A. (ABVX) reported Interest Paid Classified As Financing Activities of EUR 6.49 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2026-03-23
- Abivax S.A. interest paid classified as financing activities for the quarter ending 2025-12-31 was 1.07M EUR, a 54.20% decline year-over-year.
- Abivax S.A. interest paid classified as financing activities for the quarter ending 2025-09-30 was 1.55M EUR, a 35.49% decline year-over-year.
- Abivax S.A. interest paid classified as financing activities for the quarter ending 2025-06-30 was 1.90M EUR, a 0.95% increase year-over-year.
- Abivax S.A. interest paid classified as financing activities for the quarter ending 2025-03-31 was 1.97M EUR, a 83.64% increase year-over-year.
| Period end | Interest Paid Classified As Financing Activities 3 month | Interest Paid Classified As Financing Activities 6 month | Interest Paid Classified As Financing Activities 9 month | Interest Paid Classified As Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.07M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 2.62M EUR derived: sum of 2 quarters · filed 2026-03-23 | 4.53M EUR derived: sum of 3 quarters · filed 2026-03-23 | 6.49M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 1.55M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 3.46M EUR derived: sum of 2 quarters · filed 2025-12-15 | 5.42M EUR 6-K · filed 2025-12-15 | 7.75M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 1.90M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 3.87M EUR 6-K · filed 2025-09-08 | 6.20M EUR derived: sum of 3 quarters · filed 2026-03-23 | 8.61M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 1.97M EUR 6-K · filed 2025-06-02 | 4.30M EUR derived: sum of 2 quarters · filed 2026-03-23 | 6.71M EUR derived: sum of 3 quarters · filed 2026-03-23 | 8.59M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 2.33M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 4.74M EUR derived: sum of 2 quarters · filed 2026-03-23 | 6.63M EUR derived: sum of 3 quarters · filed 2026-03-23 | 7.70M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 2.41M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 4.29M EUR derived: sum of 2 quarters · filed 2025-12-15 | 5.36M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 1.89M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 2.96M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 1.07M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 5.28M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | 4.01M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 1.91M EUR 20-F · filed 2024-04-05 |